Skip to main content
SpringerLink
Log in

Cyclosporine effects on optic nerve and retinal vasculitis in Behcet's disease

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

In a prospective, open clinical trial, we studied long-term effects of cyclosporine (CsA) on the optic nerve and retinal vasculitis in 14 Behcet's disease patients. Patients were treated with CsA and corticosteroids for a mean period of 42 months, with a range of 36 to 52 months. They received an initial CsA dosage of 7 mg/kg/day for three days, followed by 5 mg/kg/day, and prednisone 1 mg/kg/day for three to five days, tapered to 0.4 mg/kg/day. CsA was tapered when clinical response was noted. Improvement occurred in visual acuity and visual field defects secondary to papillitis, optic neuritis, macular neuroretinitis, and retinal phlebitis, but not with retinal arteritis. Despite a 12/14 (85%) exacerbation rate, no permanent liver or renal lab tests abnormalities were noted. Intermittent, low-dose CsA therapy may be considered in treatment of acute retinal and optic nerve vasculitis assisted with Behcet's disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Behcet H. Über Rez idivierende Aphthose, durch ein Virus verusachte Geschwure and Munde, am Auge, and am den Genitalien. Dermatol Wochenschr 1937; 105: 1152–1157.

    Google Scholar 

  2. Behcet's Disease Research Committee of Japan. Behcet's disease: Guide to diagnosis of Behcet's disease. Jpn J Ophthalmol 1974; 18: 291–294.

    Google Scholar 

  3. Colvard DM, Robertson DM, O'Duffy JD. The ocular manifestations of Behcet's disease. Arch Ophthalmol 1977; 95: 1813–1817.

    Google Scholar 

  4. Cotticelli L, Apponi-Battini G, Federico A, et al. Behcet's disease: An unusual case with bilateral obliterating retina panarteritis and ischemic optic atrophy. Ophthalmologica 1980; 180: 328–332.

    Google Scholar 

  5. Benezra D, Cohen E. Treatment and visual prognosis in Behcet's disease. Br J Ophthalmol 1986; 70: 589–592.

    Google Scholar 

  6. Chung YM, Liu JH, Su-Tsu ST. Behcet's disease in Taiwan. Jpn J Ophthalmol 1986; 30: 318–323.

    Google Scholar 

  7. Bietti GB, Bruna F. An ophthalmic report on Behcet's disease. In: Monacelli MM, Nazarro P, eds. Behcet's Disease. Basel (Switzerland): Karger, 1966: 79–110.

    Google Scholar 

  8. Mamo JG. The rate of visual loss in Behcet's disease. Arch Ophthalmol 1970; 84: 451–452.

    Google Scholar 

  9. Ohno S, Higuchi M, Ohguchi M, et al. Clinical attempts of immunotherapy in Behcet's disease. In: International Conference on Behcet's Disease, 23–24 October 1981. Keidanren-Kaiken, Tokyo (Japan): Japan Medical Research Foundation, 1981: 63.

    Google Scholar 

  10. Yamana S, Yamanato M, Aai K, et al. Long-term observation of patients with Behcet's disease treated with colchicine. In: International Conference on Behcet's Disease, 23–24 October 1981. Kaidanren-Kaiken, Tokyo (Japan): Japan Medical Research Foundation, 1981: 69.

    Google Scholar 

  11. Shemakawa M, Ono Y, Kogure M. Treatment of Behcet's disease. In: International Conference on Behcet's Disease, 23–24 October 1981. Kaidanren-Kaiken, Tokyo (Japan): Japan Medical Research Foundation, 1981: 69.

    Google Scholar 

  12. Wolf RE, Fudenberg HH, Welch TN, et al. Treatment of Behcet's syndrome with transfer factor. JAMA 1977; 238: 869–887.

    Google Scholar 

  13. Tabbara KF. Chlorambucil in Behcet's disease. Ophthalmology 1983; 90: 906–908.

    Google Scholar 

  14. O'Duffy JD, Robertson DM, Goldstein NP. Chlorambucil in the treatment of uveitis and meningoencephalitis of Behcet's disease. Am J Med 1984; 76: 75–84.

    Google Scholar 

  15. Aoki K, Suguira S. Immuno-suppressive treatment of Behcet's disease. Mod Probl Ophthalmol 1976; 16: 309–313.

    Google Scholar 

  16. Buckley GE III, Gills JB Jr. Cyclophosphamide therapy of Behcet's disease. J Allergy 1969; 43: 273–283.

    Google Scholar 

  17. Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol 1983; 96: 275–282.

    Google Scholar 

  18. Muftuoglu AU, Pazarli H, Yurdakul S, et al. Short term cyclosporin A treatment of Behcet's disease. Br J Ophthalmol 1987; 71: 387–390.

    Google Scholar 

  19. Nussenblatt RB, Dunning WJ, Fujikawa LS, et al. Local cyclosporin therapy for experimental autoimmune uveitis in rats. Arch Ophthalmol 1985; 103: 1559–1562.

    Google Scholar 

  20. Nussenblatt RB, Palestine AG, Chan CC, et al. Standardization of visual inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985; 92: 467–477.

    Google Scholar 

  21. Van Buren CT. Cyclosporine: progress, problems, and perspectives. Surg Clin North Am 1986; 66(3): 435–449.

    Google Scholar 

  22. Binder AI, Graham EM, Sanders MD, et al. Cyclosporin A in the treatment of severe Behcet's uveitis. Br J Rheumatol 1987; 26(4): 285–291.

    Google Scholar 

  23. Chamberlain, MA. Behcet's syndrome in 32 patients in Yorkshire. Annals of Rheumatic Diseases 1977; 36: 491–499.

    Google Scholar 

  24. Mochizuki M, Nussenblatt RB, Kuwara T, et al. Effects of cyclosporin and other immuno-suppressive drugs on experimental auto-immune uveoretinitis in rats. Invest Ophthalmol Vis Sci 1985; 26: 226–232.

    Google Scholar 

  25. Vries J de, Baarsma GS, Zaal MJW, et al. Cyclosporin in the treatment of severe chronic idiopathic uveitis. Br J Ophthalmol 1990; 74: 344–349.

    Google Scholar 

  26. Diaz-Llopis M, Cervera M, Menezo JL. Cyclosporin A treatment of Behcet's disease: a long term study. Curr Eye Res 1990; 9: 17–23.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia

    Pamela S. Chavis MD & Sobhi R. Antonios

  2. Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia

    Khalid F. Tabbara

Authors
  1. Pamela S. Chavis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sobhi R. Antonios
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Khalid F. Tabbara
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chavis, P.S., Antonios, S.R. & Tabbara, K.F. Cyclosporine effects on optic nerve and retinal vasculitis in Behcet's disease. Doc Ophthalmol 80, 133–142 (1992). https://doi.org/10.1007/BF00161239

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00161239

Key words

Search

Navigation